Showing results (51-60 of 525) with videos related to
Sort By:
Pageof 53
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1979
Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferonW E Seaman, T C Merigan, N TalalAntimicrobial Agents and Chemotherapy|August 3, 1999
Hydroxyurea enhances the activities of didanosine, 9-[2-(phosphonylmethoxy)ethyl]adenine, and 9-[2-(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolatesS Palmer, R W Shafer, T C MeriganLancet (London, England)|June 27, 1981
Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infectionsS Chou, J G Gallagher, T C MeriganJournal of Acquired Immune Deficiency Syndromes|January 1, 1991
Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virusD H Schwartz, G Skowron, T C MeriganJournal of Immunology (Baltimore, Md. : 1950)|November 15, 1986
Regulation of guinea-pig immune functions by interleukin 2: critical role of natural killer activity in acute HSV-2 genital infectionA Weinberg, T Y Basham, T C MeriganAIDS (London, England)|July 9, 1999
Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical developmentS Palmer, R W Shafer, T C MeriganJournal of Clinical Microbiology|January 1, 1995
Quantitative analysis of syncytium-inducing and non-syncytium-inducing virus in patients infected with human immunodeficiency virus type 1R W Shafer, E Aguiniga, T C MeriganIntervirology|January 1, 1978
Factors affecting the interferon sensitivity of human cytomegalovirusA R Holmes, L Rasmussen, T C MeriganAnnals of Internal Medicine|November 1, 1984
Survival in chronic hepatitis B. An analysis of 379 patientsJ I Weissberg, L L Andres, C I Smith, et al.Vaccine|January 1, 1992
Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigsR J Ho, R L Burke, T C MeriganPageof 53